| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
| mRNA |
procarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
| mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0036 |
0.9 |
| mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
| mRNA |
LY317615 |
GDSC1000 |
pan-cancer |
AAC |
0.0033 |
0.9 |
| mRNA |
KIN001-244 |
GDSC1000 |
pan-cancer |
AAC |
0.003 |
0.9 |
| mRNA |
serdemetan |
FIMM |
pan-cancer |
AAC |
0.015 |
0.9 |
| mRNA |
JW-480 |
CTRPv2 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
| mRNA |
prochlorperazine |
CTRPv2 |
pan-cancer |
AAC |
0.0033 |
0.9 |
| mRNA |
SB52334 |
GDSC1000 |
pan-cancer |
AAC |
0.0028 |
0.9 |